Neuland Laboratories Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Cash & Equivalents	-	1,319	875.75	454.16	50.91	24.36
Short-Term Investments	-	1,077	-	-	33.77	64.56
Cash & Short-Term Investments	1,687	2,396	875.75	454.16	84.68	88.91
Cash Growth	-11.37%	173.61%	92.83%	436.31%	-4.76%	-52.46%
Accounts Receivable	-	3,162	3,760	3,687	2,380	2,207
Other Receivables	-	79.78	70.45	31.6	35.16	16.66
Receivables	-	3,242	3,830	3,719	2,415	2,223
Inventory	-	3,858	3,504	2,792	2,652	2,476
Prepaid Expenses	-	117.18	111.41	105.38	74.16	71.75
Other Current Assets	-	1,782	889.07	538.4	582.18	635.87
Total Current Assets	-	11,395	9,211	7,609	5,808	5,496
Property, Plant & Equipment	-	7,183	5,686	4,980	4,866	4,312
Long-Term Investments	-	15.29	12.79	5.25	4.97	4.4
Goodwill	-	2,795	2,795	2,795	2,795	2,795
Other Intangible Assets	-	48.54	24.58	13.01	21.2	34.98
Other Long-Term Assets	-	362.74	596.7	395.86	340.41	605.74
Total Assets	-	21,799	18,326	15,798	13,835	13,248
Accounts Payable	-	2,522	1,920	1,710	1,174	1,521
Accrued Expenses	-	841.95	1,060	626.39	451.21	480.95
Short-Term Debt	-	-	-	111.58	922.15	569.84
Current Portion of Long-Term Debt	-	452.83	375.86	361.07	344.84	250.58
Current Portion of Leases	-	25.1	36.79	30.92	26.46	25.32
Current Income Taxes Payable	-	0.89	0.81	104.02	-	-
Other Current Liabilities	-	814.07	883.53	1,446	713.08	837.07
Total Current Liabilities	-	4,657	4,277	4,390	3,632	3,685
Long-Term Debt	-	907.27	449.21	742.46	1,042	881.33
Long-Term Leases	-	186.18	92.03	38.48	69.4	95.86
Long-Term Unearned Revenue	-	-	-	-	-	0.3
Pension & Post-Retirement Benefits	-	23.72	36.54	70.08	86.92	68.61
Long-Term Deferred Tax Liabilities	-	728.22	604.39	582.99	566.99	597.57
Other Long-Term Liabilities	-	48.5	39.56	33.11	32.52	54.53
Total Liabilities	-	6,551	5,499	5,857	5,430	5,383
Common Stock	-	128.3	128.3	128.3	128.3	128.3
Additional Paid-In Capital	-	4,978	4,978	4,978	4,978	4,978
Retained Earnings	-	10,225	7,804	4,931	3,360	2,761
Comprehensive Income & Other	-	-83.24	-82.79	-96.38	-61.31	-2.01
Total Common Equity	16,202	15,248	12,827	9,941	8,405	7,865
Shareholders' Equity	16,202	15,248	12,827	9,941	8,405	7,865
Total Liabilities & Equity	-	21,799	18,326	15,798	13,835	13,248
Total Debt	2,645	1,571	953.9	1,284	2,405	1,823
Net Cash (Debt)	-958.12	824.76	-78.14	-830.34	-2,321	-1,734
Net Cash Per Share	-74.68	64.28	-6.09	-64.72	-180.88	-135.15
Filing Date Shares Outstanding	12.83	12.83	12.83	12.83	12.83	12.83
Total Common Shares Outstanding	12.83	12.83	12.83	12.83	12.83	12.83
Working Capital	-	6,738	4,934	3,219	2,176	1,811
Book Value Per Share	1262.78	1188.48	999.78	774.83	655.11	612.99
Tangible Book Value	13,318	12,405	10,008	7,133	5,589	5,035
Tangible Book Value Per Share	1038.06	966.88	780.04	555.99	435.64	392.44
Land	-	330.91	287.48	107.43	107.43	107.43
Buildings	-	2,342	2,049	1,820	1,722	1,375
Machinery	-	6,554	5,336	4,635	4,337	3,754
Construction In Progress	-	445.53	458.91	405.66	204.57	172.5

Source: S&P Global Market Intelligence. Standard template. Financial Sources.